Chemomab Therapeutics Ltd.
What this means
- Net loss in 2025Net loss of $9M for the year (2024: −$13.9M).
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Net income (loss) | −$9M | −$13.9M |
| Total assets | $13.8M | $17M |
| Total liabilities | $1.5M | $3.4M |
| Stockholders’ equity | $12.3M | $13.5M |
| Cash and equivalents | $7.6M | $6.1M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- Chemomab Therapeutics Ltd.
Formerly: Anchiano Therapeutics Ltd. - CIK
- 0001534248
- Tickers
- CMMB
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company - Status
- Filing with the SEC
- State of incorporation
- Israel
- Business address
- Tel Aviv, Massachusetts
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 20-F for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Mar 31, 2023
- Bankruptcy reported
- Not in our data
- Last edition event
- Nov 10, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form SCHEDULE 13D · filed Nov 10, 2026 · filing · edition of Nov 10, 2026
- Form SCHEDULE 13D · filed Jul 16, 2026 · filing
- Form 20-F · filed Mar 23, 2026 · filing
- Form 20-F · filed Apr 4, 2025 · filing
- Form D · items 06b · filed Aug 9, 2024 · filing
- Form 20-F · filed Mar 28, 2024 · filing
- Form 8-K · items 5.02 · filed Jun 16, 2023 · filing
- Form 8-K · items 5.02, 7.01, 9.01 · filed Jun 5, 2023 · filing
- Form 10-Q · filed May 11, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed May 11, 2023 · filing
- Form 10-K · filed Mar 20, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Feb 21, 2023 · filing
- Form S-1 · filed Jan 13, 2023 · filing